Growth hormone replacement in patients with non-functioning pituitary adenoma treated solely by surgery is not associated with increased risk of tumour recurrence.

Background: Subjects with non-functioning pituitary adenomas (NFAs) frequently develop growth hormone deficiency due to tumour expansion or as a consequence of tumour therapy. The safety of growth hormone replacement (GHR) in these individuals remains unclear. Objective: To assess the effect of GHR...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí: Arnold, J, Arnold, D, Marland, A, Karavitaki, N, Wass, J
Formáid: Journal article
Teanga:English
Foilsithe / Cruthaithe: 2008